See a new technique to treat severe asthma.
November 16th, 2026FDA Approves Gefurulimab as First Once-Weekly, Self-Administered C5 Inhibitor for gMGAdults with AChR antibody–positive generalized myasthenia gravis now have a C5 inhibitor they can inject themselves at home once a week.Read more